| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.8M | -33.0% | -32.1% |
| Cost of Revenue | $5.5M | -35.7% | -31.6% |
| Gross Profit | $263K | +579.2% | -40.7% |
| R&D Expense | $85K | +9.9% | -41.9% |
| SG&A Expense | $1.2M | -16.2% | -26.4% |
| Operating Income | -$1.7M | -14.3% | -5.4% |
| Pre-tax Income | -$1.7M | -8.5% | -1.1% |
| Income Tax | $57 | — | +0.0% |
| Net Income | -$1.7M | -8.4% | -0.6% |
| EPS (Basic) | -$0.03 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.03 | +0.0% | +0.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24K | -89.1% | -85.3% |
| Accounts Receivable | $44.2M | +17.1% | +67.7% |
| Inventory | $116K | -6.3% | +272.2% |
| Current Assets | $51.0M | +13.1% | +60.5% |
| Total Assets | $60.1M | +15.7% | +88.0% |
| Current Liabilities | $43.7M | +18.7% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | — |
| Capital Expenditures | $20K | — | — |
| Investing Cash Flow | -$20K | — | — |
| Financing Cash Flow | $2.6M | — | — |
| Free Cash Flow | -$3.7M | — | — |
| +95.8% |
| Total Liabilities | $43.7M | +18.7% | +95.5% |
| Stockholders' Equity | $16.4M | +8.5% | +70.0% |